How to Start Methimazole in Adults with Hyperthyroidism
Initiate methimazole at 15 mg daily for mild hyperthyroidism, 30-40 mg daily for moderate disease, or 60 mg daily for severe hyperthyroidism, divided into three doses given every 8 hours. 1
Initial Dosing Strategy
The FDA-approved dosing is straightforward and severity-based 1:
- Mild hyperthyroidism: 15 mg/day divided into 3 doses (5 mg every 8 hours)
- Moderately severe hyperthyroidism: 30-40 mg/day divided into 3 doses (10-13.3 mg every 8 hours)
- Severe hyperthyroidism: 60 mg/day divided into 3 doses (20 mg every 8 hours)
For severe hyperthyroidism (free T4 ≥7 ng/dL), start with 30 mg daily as this normalizes thyroid function more rapidly than lower doses, achieving euthyroidism in 96.5% of patients by 12 weeks. 2 In contrast, 15 mg daily is appropriate for mild-to-moderate disease and causes fewer adverse effects, particularly hepatotoxicity. 2
Key Factors Affecting Response Time
The main determinants of how quickly patients respond to methimazole are 3:
- Pretreatment T3 levels (higher levels = slower response)
- Goiter size (larger goiters = slower response)
- Daily methimazole dose (higher doses = faster response)
- Urinary iodine excretion (>100 mcg/g creatinine = delayed response)
Patients with large goiters, high pretreatment thyroid hormone levels, and elevated TSH receptor antibodies require longer to achieve euthyroidism. 3
Monitoring Requirements
Patients must be counseled to immediately report sore throat, fever, skin eruptions, headache, or general malaise, as these may indicate agranulocytosis. 1 Obtain white blood cell count with differential if any of these symptoms occur. 1
Additional monitoring includes 1:
- Thyroid function tests periodically during therapy
- Prothrombin time before surgical procedures (methimazole may cause hypoprothrombinemia)
- Rising TSH indicates need for dose reduction once hyperthyroidism resolves
Titration to Maintenance Dose
Once euthyroidism is achieved, reduce to a maintenance dose of 5-15 mg daily. 1 The European Thyroid Association recommends treating for 12-18 months with methimazole as the preferred antithyroid drug. 4
Special Populations and Precautions
Women planning pregnancy or in the first trimester should be switched to propylthiouracil, as methimazole crosses the placenta and is associated with rare congenital malformations during organogenesis. 1 However, methimazole can be resumed in the second and third trimesters given propylthiouracil's hepatotoxicity risk. 1
Methimazole is superior to propylthiouracil for initial treatment in non-pregnant adults, achieving faster normalization of thyroid hormones and TSH receptor antibodies with lower rates of hepatotoxicity. 2, 5
Common Pitfalls to Avoid
- Do not use once-daily dosing initially: The FDA label specifies three divided doses at 8-hour intervals for optimal efficacy 1
- Do not underdose severe hyperthyroidism: Using 15 mg daily in severe disease (FT4 ≥7 ng/dL) results in significantly slower normalization compared to 30 mg daily 2
- Do not ignore minor allergic reactions: If urticaria develops, do not permanently discontinue methimazole; after resolution with antihistamines, gradually reintroduce starting at one-quarter dose with concurrent cetirizine, escalating to full dose over 10 days 6
- Do not forget drug interactions: Adjust doses of warfarin, beta-blockers, digoxin, and theophylline as patients become euthyroid, as clearance of these drugs changes with thyroid status 1